hVIVO (LON:HVO) Stock Crosses Below 200 Day Moving Average – Should You Sell?

hVIVO plc (LON:HVO)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 28.25 ($0.37) and traded as low as GBX 26.70 ($0.35). hVIVO shares last traded at GBX 27.30 ($0.36), with a volume of 10,117,770 shares trading hands.

hVIVO Stock Up 1.1 %

The company’s 50-day moving average price is GBX 28.75 and its 200 day moving average price is GBX 28.25. The company has a debt-to-equity ratio of 33.86, a quick ratio of 1.16 and a current ratio of 1.61. The stock has a market cap of £185.74 million, a PE ratio of 910.00 and a beta of 0.97.

Insider Buying and Selling at hVIVO

In other news, insider Cathal Friel sold 21,159,176 shares of the business’s stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of GBX 29 ($0.38), for a total transaction of £6,136,161.04 ($8,030,573.28). 14.03% of the stock is owned by corporate insiders.

hVIVO Company Profile

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.